Concepedia

Satoshi Ishiyama

SI

Statistics

Publications

12

Citations

910

H-Index

12

Active since

1980

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Jikei University School of Medicine

The University of Tokyo

Kyoto University

Nikon (Japan)

Satoshi Ishiyama is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pancreatic cancer.

Publications per year

1980–2023

12

Publications

12

LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

Davide Melisi, Satoshi Ishiyama, Guido M. Sclabas et al. · Molecular Cancer Therapeutics · 2008 · 317 citations · Full text

Medicine, Oncology, Pharmacology +17

Structure of the Dnmt1 Reader Module Complexed with a Unique Two-Mono-Ubiquitin Mark on Histone H3 Reveals the Basis for DNA Methylation Maintenance

Satoshi Ishiyama, Atsuya Nishiyama, Yasushi Saeki et al. · Molecular Cell · 2017 · 193 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Secreted Interleukin-1α Induces a Metastatic Phenotype in Pancreatic Cancer by Sustaining a Constitutive Activation of Nuclear Factor-κB

Davide Melisi, Jiangong Niu, Zhe Chang et al. · Molecular Cancer Research · 2009 · 90 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells

Naotake Tsuda, Satoshi Ishiyama, Yufeng Li et al. · Clinical Cancer Research · 2006 · 77 citations · Full text

Life Sciences, Cancer Biology, Molecular Biology +17

Expression of Concern: Mechanisms of synthetic serine protease inhibitor (FUT‐175)‐mediated cell death

Tadashi Uwagawa, Zhongkui Li, Zhe Chang et al. · Cancer · 2007 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 12